Methylenetetrahydrofolate Reductase Polymorphisms As Genetic Markers to Predict Homocysteinemia and Clinical Severity in Sickle Cell Disease

References

• Meher S , PatelS, DasKet al. Association of plasma homocysteine level with vaso-occlusive crisis in sickle cell anemia patients of Odisha, India. Ann. Hematol.98(10), 2257–2265 (2019).
   PubMed Web of Science ®Google Scholar
• Adelekan OO , UcheEI, BalogunTMet al. Methylene tetrahydrofolate reductase gene mutation in sickle cell anaemia patients in Lagos, Nigeria. Pan. Afr. Med. J.34, 213 (2019).
   PubMed Web of Science ®Google Scholar
• Uche E , AdelekanO, AkinbamiAet al. Serum homocysteine and disease severity in sickle cell anemia patients in Lagos. J. Blood. Med.10, 127–134 (2019).
   PubMed Web of Science ®Google Scholar
• van der Put NM , GabreëlsF, StevensEMet al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am. J. Hum. Genet. 62(5), 1044–1051 (1998).
   PubMed Web of Science ®Google Scholar
• Weisberg I , TranP, ChristensenB, SibaniS, RozenR. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol. Genet. Metab.64(3), 169–172 (1998).
   PubMed Web of Science ®Google Scholar
• Yang B , LiuY, LiYet al. Geographical distribution of MTHFR C677T, A1298C and MTRR A66G gene polymorphisms in China: findings from 15357 adults of Han nationality. PLoS ONE8(3), e57917 (2013).
   PubMed Web of Science ®Google Scholar
• Panigrahi S , PatraPK, KhodiarPK. The screening and morbidity pattern of sickle cell anemia in Chhattisgarh. Indian J. Hematol. Blood Transfus.31(1), 104–109 (2015).
   PubMed Web of Science ®Google Scholar
• Devi ARR , GovindaiahV, RamakrishnaG, NaushadSM. Prevalence of methylene tetrahydrofolate reductase polymorphism in South Indian population. Curr. Sci.86(3), 440–443 (2004).
   Web of Science ®Google Scholar
• Hatzlhofer BLD , BezerraMAC, SantosMNNet al. MTHFR polymorphic variant C677T is associated to vascular complications in sickle-cell disease. Genet. Test. Mol. Biomark.16(9), 1038–1043 (2012).
   PubMed Web of Science ®Google Scholar
• Kangne HK , JijinaFF, ItaliaYMet al. The prevalence of factor V Leiden (G1691A) and methylenetetrahydrofolate reductase C677T mutations in sickle cell disease in Western India. Clin. Appl. Thromb. Hemost.21(2), 186–189 (2015).
   PubMed Web of Science ®Google Scholar
• Al-Absi IK , Al-SubaieAM, AmeenGet al. Association of the methylenetetrahydrofolate reductase A1298C but not the C677T single-nucleotide polymorphism with sickle cell disease in Bahrain. Hemoglobin30(4), 449–453 (2006).
   PubMed Web of Science ®Google Scholar
• Nishank SS , SinghMPSS, YadavR. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India. Eur. J. Haematol.91(5), 462–466 (2013).
   PubMed Web of Science ®Google Scholar
• el-Hazmi MA . Clinical and haematological diversity of sickle cell disease in Saudi children. J. Trop. Pediatr.38(3), 106–112 (1992).
   PubMed Web of Science ®Google Scholar
• Hu Z , ChangSM, YounisR, AlvarezOA. Optimal hemoglobin level for pediatric sickle cell patients who undergo adenotonsillectomy. Blood132(Suppl. 1), 4938–4938 (2018).
   Google Scholar
• Hoss GRW , PoloniS, BlomHJ, SchwartzIVD. Three main causes of homocystinuria: CBS, cblC and MTHFR deficiency. What do they have in common?J. Inborn Errors Metab. Screen.7, e20190007 (2019).
   Google Scholar
• Al-Saqladi A-WM , HarperG, DelpishehA, FijnvandraatK, Bin-GadeemHA, BrabinBJ. Frequency of the MTHFR C677T polymorphism in Yemeni children with sickle cell disease. Hemoglobin34(1), 67–77 (2010).
   PubMed Web of Science ®Google Scholar
• Pandey S , PandeyHR, MishraRM, PandeySW, SaxenaR. Increased homocysteine level in Indian sickle cell anemia patients. Indian J. Clin. Biochem.27(1), 103–104 (2012).
   PubMedGoogle Scholar
• Pushpakumar S , KunduS, SenU. Endothelial dysfunction: the link between homocysteine and hydrogen sulfide. Curr. Med. Chem.21(32), 3662–3672 (2014).
   PubMed Web of Science ®Google Scholar
• Al-Obaidi Mohamed K , HelenP, StubbsPeter Jet al. Relationships between homocysteine, factor VIIa, and thrombin generation in acute coronary syndromes. Circulation101(4), 372–377 (2000).
   PubMed Web of Science ®Google Scholar
• Gerdes VEA , HovingaHAK, CateHTet al. Homocysteine and markers of coagulation and endothelial cell activation. J. Thromb. Haemostas.2(3), 445–451 (2004).
   PubMed Web of Science ®Google Scholar
• Olaniyi JA , AKinladeKS, AtereAD, ArinolaOG. Plasma homocysteine, methyl-malonic acid, vitamin B12 and folate levels in adult Nigerian sickle cell anaemia patients. J. Adv. Medicine Med. Res.4(6), 1327–1334 (2014).
   Google Scholar
• Lowenthal EA , MayoMS, CornwellPE, Thornley-BrownD. Homocysteine elevation in sickle cell disease. J. Am. Coll. Nutr.19(5), 608–612 (2000).
   PubMed Web of Science ®Google Scholar
• van der Dijs FPL , SchnogJ-JB, BrouwerDAJet al. Elevated homocysteine levels indicate suboptimal folate status in pediatric sickle cell patients. Am. J. Hematol.59(3), 192–198 (1998).
   PubMed Web of Science ®Google Scholar
• Dixit R , NettemS, MadanSSet al. Folate supplementation in people with sickle cell disease. Cochrane Database Syst. Rev. (3), CD011130 (2018).
   PubMed Web of Science ®Google Scholar
• Williams BA , McCartneyH, AdamsEet al. Folic acid supplementation in children with sickle cell disease: study protocol for a double-blind randomized cross-over trial. Trials21(1), 593 (2020).
   PubMedGoogle Scholar
• Patel S , NandaR, HussainN, MohapatraE, PatraPK. Frequency distribution of the methylenetetrahydrofolate reductase polymorphisms in sickle cell hemoglobinopathy-A hospital based study in central India. Clin. Epidemiol. Glob. Health10, 100669 (2021).
   Web of Science ®Google Scholar